Cargando…

Synthesis of Novel, Dual-Targeting (68)Ga-NODAGA-LacN-E[c(RGDfK)](2) Glycopeptide as a PET Imaging Agent for Cancer Diagnosis

Radiolabeled peptides possessing an Arg-Gly-Asp (RGD) motif are widely used radiopharmaceuticals for PET imaging of tumor angiogenesis due to their high affinity and selectivity to α(v)β(3) integrin. This receptor is overexpressed in tumor and tumor endothelial cells in the case of numerous cancer c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gyuricza, Barbara, Szabó, Judit P., Arató, Viktória, Szücs, Dániel, Vágner, Adrienn, Szikra, Dezső, Fekete, Anikó
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227980/ https://www.ncbi.nlm.nih.gov/pubmed/34073528 http://dx.doi.org/10.3390/pharmaceutics13060796

Ejemplares similares

Synthesis of (68)Ga-Labeled cNGR-Based Glycopeptides and In Vivo Evaluation by PET Imaging
por: Gyuricza, Barbara, et al.
Publicado: (2021)

PET Probes for Preclinical Imaging of GRPR-Positive Prostate Cancer: Comparative Preclinical Study of [(68)Ga]Ga-NODAGA-AMBA and [(44)Sc]Sc-NODAGA-AMBA
por: Kálmán-Szabó, Ibolya, et al.
Publicado: (2022)

Investigation of the Effect on the Albumin Binding Moiety for the Pharmacokinetic Properties of (68)Ga-, (205/206)Bi-, and (177)Lu-Labeled NAPamide-Based Radiopharmaceuticals
por: Szücs, Dániel, et al.
Publicado: (2023)

The Synthesis and Preclinical Investigation of Lactosamine-Based Radiopharmaceuticals for the Detection of Galectin-3-Expressing Melanoma Cells
por: Gyuricza, Barbara, et al.
Publicado: (2022)

Synthesis, Physicochemical, Labeling and In Vivo Characterization of (44)Sc-Labeled DO3AM-NI as a Hypoxia-Sensitive PET Probe
por: Szücs, Dániel, et al.
Publicado: (2022)

Therapeutic Performance Evaluation of (213)Bi-Labelled Aminopeptidase N (APN/CD13)-Affine NGR-Motif ([(213)Bi]Bi-DOTAGA-cKNGRE) in Experimental Tumour Model: A Treasured Tailor for Oncology
por: Képes, Zita, et al.
Publicado: (2023)

Methods for the Determination of Transition Metal Impurities in Cyclotron-Produced Radiometals
por: Forgács, Viktória, et al.
Publicado: (2022)

Preparation and preclinical evaluation of a (68)Ga-labelled c(RGDfK) conjugate comprising the bifunctional chelator NODIA-Me
por: Läppchen, Tilman, et al.
Publicado: (2018)

(68)Ga-DOTA-E-[c(RGDfK)]2 positron emission tomography–computed tomography in the evaluation of hepatic hemangioendothelioma epithelioid
por: Soldevilla-Gallardo, Irma, et al.
Publicado: (2019)

Evaluation of Nanotargeted (111)In-Cyclic RGDfK-Liposome in a Human Melanoma Xenotransplantation Model
por: Liu, Si-Yen, et al.
Publicado: (2021)

Imaging angiogenesis in patients with head and neck squamous cell carcinomas by [(68)Ga]Ga-DOTA-E-[c(RGDfK)](2) PET/CT
por: Lobeek, D., et al.
Publicado: (2020)

Sialylation facilitates self-assembly of 3D multicellular prostaspheres by using cyclo-RGDfK(TPP) peptide
por: Haq, Sabah, et al.
Publicado: (2017)

Evaluation of Integrin α(v)β(3) Expression in Murine Xenograft Models: [(68)Ga]Ga-DOTA-C(RGDfK) PET Study with Immunohistochemical Confirmation
por: Mitsuyuki, Kosuke, et al.
Publicado: (2021)

In Vivo Molecular Imaging of the Efficacy of Aminopeptidase N (APN/CD13) Receptor Inhibitor Treatment on Experimental Tumors Using (68)Ga-NODAGA-c(NGR) Peptide
por: Kis, Adrienn, et al.
Publicado: (2021)

Rhenium and Technetium-oxo Complexes with Thioamide Derivatives of Pyridylhydrazine Bifunctional Chelators Conjugated to the Tumour Targeting Peptides Octreotate and Cyclic-RGDfK
por: North, Andrea J., et al.
Publicado: (2017)

Impact of Fucosylation on Self-Assembly of Prostate and Breast Tumor Spheroids by Using Cyclo-RGDfK(TPP) Peptide and Image Object Detection
por: Kalaydina, Regina-Veronicka, et al.
Publicado: (2019)

Proof-of-Concept Study of the NOTI Chelating Platform: Preclinical Evaluation of (64)Cu-Labeled Mono- and Trimeric c(RGDfK) Conjugates
por: Martin, Sebastian, et al.
Publicado: (2020)

In Vivo Imaging of Experimental Melanoma Tumors using the Novel Radiotracer (68)Ga-NODAGA-Procainamide (PCA)
por: Kertész, István, et al.
Publicado: (2017)

Utility of (99m)Tc-PEG(4)-E[PEG(4)-c(RGDfK)](2) in Posttherapy Surveillance of Patients with Reelevated Carcinoembryonic Antigen Levels
por: Gao, Rui, et al.
Publicado: (2015)

Comparison of desferrioxamine and NODAGA for the gallium-68 labeling of exendin-4
por: Kaeppeli, Simon A. M., et al.
Publicado: (2019)

In Vivo Imaging of Hypoxia and Neoangiogenesis in Experimental Syngeneic Hepatocellular Carcinoma Tumor Model Using Positron Emission Tomography
por: Kis, Adrienn, et al.
Publicado: (2020)

Positron emission tomography imaging of tumor angiogenesis and monitoring of antiangiogenic efficacy using the novel tetrameric peptide probe (64)Cu-cyclam-RAFT-c(-RGDfK-)(4)
por: Jin, Zhao-Hui, et al.
Publicado: (2012)

The anti-tumor and renoprotection study of E-[c(RGDfK)(2)]/folic acid co-modified nanostructured lipid carrier loaded with doxorubicin hydrochloride/salvianolic acid A
por: Zhang, Bing, et al.
Publicado: (2022)

First in-human radiation dosimetry of (68)Ga-NODAGA-RGDyK
por: Gnesin, Silvano, et al.
Publicado: (2017)

Preclinical validations of [(18)F]FPyPEGCBT-c(RGDfK): a (18)F-labelled RGD peptide prepared by ligation of 2-cyanobenzothiazole and 1,2-aminothiol to image angiogenesis
por: Colin, Didier J., et al.
Publicado: (2016)

Evaluation of [(68)Ga]Ga-NODAGA-RGD for PET Imaging of Rat Autoimmune Myocarditis
por: Jahandideh, Arghavan, et al.
Publicado: (2021)

Biodistribution and Internal Radiation Dosimetry of (99m)Tc-IDA-D-[c(RGDfK)](2) (BIK-505), a Novel SPECT Radiotracer for the Imaging of Integrin α(v)β(3) Expression
por: Song, Yoo Sung, et al.
Publicado: (2018)

A New Oxygen Containing Pyclen-Type Ligand as a Manganese(II) Binder for MRI and (52)Mn PET Applications: Equilibrium, Kinetic, Relaxometric, Structural and Radiochemical Studies
por: Csupász, Tibor, et al.
Publicado: (2022)

(68)Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism
por: Boss, Marti, et al.
Publicado: (2022)

Radiothérapie hypofractionnée pour le traitement de l’acné chéloïdienne de la nuque
por: Kwan, Jennifer Yin Yee, et al.
Publicado: (2022)

Successful Nerve Block Therapy for Lateral Cutaneous Nerve Entrapment Syndrome (LACNES) Triggered by Exercise
por: Yamada, Kumiko, et al.
Publicado: (2023)

Uniform intratumoral distribution of radioactivity produced using two different radioagents, (64)Cu-cyclam-RAFT-c(-RGDfK-)(4) and (64)Cu-ATSM, improves therapeutic efficacy in a small animal tumor model
por: Jin, Zhao-Hui, et al.
Publicado: (2018)

The First Dimeric Derivatives of the Glycopeptide Antibiotic Teicoplanin
por: Bereczki, Ilona, et al.
Publicado: (2022)

Brain Imaging of the GLP-1 Receptor in Obesity Using (68)Ga-NODAGA-Exendin-4 PET
por: Deden, Laura N., et al.
Publicado: (2021)

Human Dose Assessment of (68)Ga-NODAGA-RGD-BBN Heterodimer Peptide based on Animal Data
por: Amraee, Naeimeh, et al.
Publicado: (2022)

Imaging of Integrin α(v)β(3) Expression in Lung Cancers and Brain Tumors Using Single-Photon Emission Computed Tomography with a Novel Radiotracer (99m)Tc-IDA-D-[c(RGDfK)](2)
por: Song, Yoo Sung, et al.
Publicado: (2017)

PET-Based Human Dosimetry of (68)Ga-NODAGA-Exendin-4, a Tracer for β-Cell Imaging
por: Boss, Marti, et al.
Publicado: (2020)

The Role of Glucagon-Like Peptide 1 Receptor PET/CT With Ga-68-NODAGA-exendin in Localising an Insulinoma: Lessons From a Clinical Case
por: Grigoriadou, Viktoria Chatzimavridou, et al.
Publicado: (2021)

Development of (68)Ga-Glycopeptide as an Imaging Probe for Tumor Angiogenesis
por: Tsao, Ning, et al.
Publicado: (2011)

[(68)Ga]NODAGA-RGD – Metabolic stability, biodistribution, and dosimetry data from patients with hepatocellular carcinoma and liver cirrhosis
por: Haubner, Roland, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qq60b58kds80ea04ocqhrsus7p